Phase I study of chimeric anti-CD20 monoclonal antibody in Chinese patients with CD20-positive non-Hodgkin's lymphoma.
Gui L, Han X, He X, Song Y, Yao J, Yang J, Liu P, Qin Y, Zhang S, Zhang W, Gai W, Xie L, Shi Y.
Gui L, et al. Among authors: zhang s, zhang w.
Chin J Cancer Res. 2016 Apr;28(2):197-208. doi: 10.21147/j.issn.1000-9604.2016.02.07.
Chin J Cancer Res. 2016.
PMID: 27199517
Free PMC article.